Abstract

Background: Currently no information is available about the effective dose (ED) of rocuronium in Koreans. The purpose of this study was to determine the ED of rocuronium in a Korean cohort. Methods: We studied one hundred and twenty patients with a class I or II ASA physical status. Anesthesia was induced with propofol 2 mg/kg and fentanyl intravenously, and maintained by the continuous infusion of propofol 5 mg/kg/h and 100% oxygen by mask ventilation. Additional increments of fentanyl were given as required, and surface electrodes were applied over the ulnar nerve at the wrist. Before each dose of rocuronium was administered intravenously, all patients were stimulated with a 50 Hz supramaximal tetanic stimulation for 5 seconds followed by a 1 Hz single twitch stimulation for 5 minutes to stabilize muscle contraction. The control value was then calibrated by acceleromyography. Twenty female patients were cumulatively administered rocuronium, at an initial dose of followed by doses incremented by . And 100 patients were allocated to five single dose groups. Subjects these dose groups were randomly administered , , , , or of rocuronium. We recorded both the 0.1 Hz single twitch responses of the adductor pollicis and the onset times to maximal blockade. The effect of rocuronium on single twitch was calculated as % reduction versus the control. Results were expressed as means SD or as 95% confidence intervals. A P value of and were determined to be and , respectively. For men, and were , and for women, , , respectively. The and as determined by the cumulative method in women were , , respectively. As the dose of rocuronium increased, onset times decreased. Mean onset time was 178 sec. Conclusions: The mean of rocuronium in Koreans was determined to be , and the ED of women was lower than that of men. The dose-response curve of the cumulative method was positioned to the right of that of the single bolus method in women. The onset time to maximum blockade reduced as the dose was increased.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.